Neurocrine Biosciences (NASDAQ:NBIX): Q1 Non-GAAP EPS of $0.82 beats by $0.23; GAAP EPS of $0.39 misses by $0.15.
Revenue of $237.1M (+71.3% Y/Y) beats by $10.81M.
https://seekingalpha.com/news/3570427-neurocrine-biosciences-eps-beats-0_23-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.